TCL Archive Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer By Cancer History Project February 25, 2011
TCL Archive Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer By Cancer History Project February 25, 2011
TCL Archive Sentinel Node Disection No Worse Than Axillary By Cancer History Project February 25, 2011
TCL Archive Triple-Negative Breast Cancer Equally Aggressive in Whites By Cancer History Project February 25, 2011
TCL Archive RG7204 Meets Endpoints Of Extending Survival, PFS By Cancer History Project February 25, 2011
TCL Archive INSPIRE Enrollment Stopped; Thromboembolism Risk Cited By Cancer History Project February 25, 2011
TCL Archive Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone By Cancer History Project February 25, 2011
TCL Archive mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients By Cancer History Project February 25, 2011
Article Fran Visco tells the story of NBCC: “Women have declared war on breast cancer” By Cancer History Project
